세계의 환자 참여 솔루션 시장 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2033년)

Patient Engagement Solution Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

US $ 4,995 ￦ 7,259,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,602,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 12,346,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

Persistence Market Research는 세계 환자 참여 솔루션 시장에 대한 광범위한 보고서를 발표했습니다. 이 보고서는 시장 성장 촉진요인, 동향, 기회, 과제 등 필수적인 시장 역학을 상세하게 분석하여 시장 전망에 대한 귀중한 통찰력을 제공합니다.

주요 인사이트

• 환자 참여 솔루션 시장 규모(2024E) : 213억 달러
• 예측 시장 규모(2033F) : 507억 달러
• 세계 시장 성장률(CAGR 2024년부터 2033년까지) : 13.2%

환자 참여 솔루션 시장 - 보고서 범위

환자 참여 솔루션은 건강 관리의 중요한 진보이며 환자 자신의 진료에 대한 참여 향상에 중점을 둡니다. 이러한 솔루션에는 환자와 의료 종사자 간의 의사 소통을 촉진하고, 환자 교육을 강화하고, 전반적인 건강 관리 결과를 향상시키기 위해 고안된 다양한 도구와 기술이 포함됩니다. 시장에는 환자 포털, 모바일 건강 앱, 원격 모니터링 시스템 등의 플랫폼이 포함됩니다. 환자 참여 솔루션 시장의 성장은 환자 중심의 케어 중시 증가, 디지털 헬스 기술의 진보, 헬스 케어 성과의 개선 요구가 원동력이 되고 있습니다.

시장 성장 촉진요인:

세계 환자 참여 솔루션 시장은 개인화된 환자 중심 건강 관리 서비스에 대한 수요 증가와 같은 몇 가지 중요한 요인에 의해 견인되고 있습니다. 원격 의료, 모바일 헬스 용도, 웨어러블 디바이스 등 디지털 헬스의 기술적 진보가 환자 참여를 강화하고 시장 확대를 촉진하고 있습니다. 또한 만성질환 관리와 예방의료에 대한 관심 증가는 이러한 솔루션이 건강 상태를 더 잘 모니터링하고 관리할 수 있게 함으로써 시장 확대에 기여하고 있습니다. 또한, 환자 관리 및 결과 개선을 목적으로 하는 정부의 지원과 건강 관리 개혁은 환자 참여 솔루션의 채택을 더욱 강화하고 있습니다.

시장 성장 억제요인:

시장 성장 가능성에도 불구하고 환자 참여 솔루션 시장은 데이터 보안, 개인 정보 보호 및 기술 통합과 관련된 과제에 직면 해 있습니다. 환자 데이터의 보안과 프라이버시 보장은 신뢰성 유지와 HIPAA와 같은 규정 준수를 위해 매우 중요합니다. 환자 참여 솔루션과 기존 건강 관리 시스템 간의 통합은 복잡하고 비용이 많이 들기 때문에 의료 제공업체에게 어려움을 겪고 있습니다. 또한 환자층이 디지털 건강 리터러시 및 기술에 액세스하는 데 격차가 있어 이러한 솔루션의 보급을 방해할 수 있습니다.

시장 기회:

환자 참여 솔루션 시장은 기술 혁신과 진화하는 건강 관리 모델을 통해 큰 성장 기회를 제공합니다. 인공지능(AI)과 머신러닝을 환자 참여 플랫폼에 통합함으로써 개인화 관리 및 예측 분석을 강화할 수 있습니다. 또한 의료 서비스에 대한 액세스가 제한될 수 있는 미개척 지역 및 농촌 지역에도 이러한 솔루션을 확장할 수 있는 기회가 있습니다. 기술 공급자, 건강 관리 조직 및 지불자의 전략적 파트너십은 새로운 비즈니스 모델을 창출하고 시장 성장을 가속할 수 있습니다. 게다가, 가치관에 근거한 케어와 환자 만족도에 대한 주목이 높아짐에 따라, 혁신적인 환자 참여 솔루션의 개발 기회가 생깁니다.

이 보고서에서 다루는 주요 질문

• 환자 참여 솔루션 시장의 세계 성장을 가속하는 주요 요인은 무엇인가?
• 어떤 유형의 환자 참여 솔루션이 각 지역에서 지지를 받고 있는가?
• 기술 진보는 환자 참여 시장 경쟁 구도를 어떻게 바꾸고 있는가?
• 환자 참여 솔루션 시장에 기여하는 주요 기업은 누군가와 시장의 관련성을 유지하기 위해 어떤 전략을 채택합니까?
• 세계 환자 참여 솔루션 시장의 새로운 동향과 미래 전망은?

목차

제1장 주요 요약

제2장 시장 개요

• 시장 범위/분류
• 시장의 정의/범위/제한

제3장 주요 시장 동향

• 시장에 영향을 주는 주요 동향
• 제품 혁신/개발 동향

제4장 가격 분석

• 솔루션별 가격 분석
  • 구독 가격 모델
  • 영구 라이선싱
• 평균 가격 분석 벤치마크

제5장 세계의 환자 참여 솔루션 시장 수요(금액: 10억 달러) 분석

• 시장 매출(10억 달러) 분석, 2019-2023년
• 시장 매출(10억 달러) 예측, 2024-2033년
  • 전년대비 성장 동향 분석
  • 절대 수익 기회

제6장 시장 배경

• 거시경제 요인
• 예측 요인- 관련성과 영향
• 밸류체인
• COVID-19 위기- 영향 평가
• 시장 역학

제7장 환자 참여 솔루션 세계 시장 분석 : 솔루션별

• 소개/주요 조사 결과
• 솔루션별 시장 규모(10억 달러) 분석, 2019-2023년
• 솔루션별 시장 규모(10억 달러) 분석과 예측, 2024-2033년
  • 소프트웨어
    • 통합된 환자 참여 소프트웨어
    • 독립형 소프트웨어
      • 스케줄 관리 소프트웨어
      • 청구 소프트웨어
      • 보안 메시징 소프트웨어
      • 기타
  • 서비스
    • 구현 및 통합
    • 컨설팅
    • 지원 및 유지 보수
• 솔루션별 시장의 매력 분석

제8장 환자 참여 솔루션 세계 시장 분석 : 전개별

• 소개/주요 조사 결과
• 시장 규모(10억 달러) 분석, 전개별, 2019-2023년
• 시장 규모(10억 달러) 분석과 예측, 전개별, 2024-2033년
  • 클라우드
  • 온프레미스
• 전개별 시장의 매력 분석

제9장 세계 환자 인게이지먼트 솔루션 시장 분석 : 용도별

• 소개/주요 조사 결과
• 시장 규모(10억 달러) 분석, 용도별, 2019-2023년
• 시장 규모(10억 달러) 분석과 예측, 용도별, 2024-2033년
  • 건강 관리
  • 소셜 매니지먼트
  • 재택 건강 관리 관리
  • 재무 건전성 관리
  • 기타
• 용도별 시장의 매력 분석

제10장 세계 환자 참여 솔루션 시장 분석 : 최종 사용자별

• 소개/주요 조사 결과
• 시장 규모(10억 달러) 분석, 최종 사용자별, 2019-2023년
• 시장 규모(10억 달러) 분석과 예측, 최종 사용자별, 2024-2033년
  • 환자
  • 지불자
  • 의료 제공자
  • 기타
• 최종 사용자별 시장의 매력 분석

제11장 세계의 환자 참여 솔루션 시장 분석 : 지역별

• 소개/주요 조사 결과
• 시장 규모(10억 달러) 분석, 지역별, 2019-2023년
• 시장 규모(10억 달러) 분석과 예측, 지역별, 2024-2033년
  • 북미
  • 라틴아메리카
  • 유럽
  • 동아시아
  • 남아시아태평양
  • 중동 및 아프리카
• 지역별 시장의 매력 분석

제12장 북미 환자 인게이지먼트 솔루션 시장 분석

제13장 라틴아메리카 환자 참여 솔루션 시장 분석

제14장 유럽 환자 참여 솔루션 시장 분석

제15장 남아시아 및 태평양 지역의 환자 참여 솔루션 시장 분석

제16장 동아시아 환자 참여 솔루션 시장 분석

제17장 중동 및 아프리카 환자 참여 솔루션 시장 분석

제18장 환자 참여 솔루션 시장의 주요 국가 분석

• 미국
• 캐나다
• 멕시코
• 브라질
• 독일
• 이탈리아
• 프랑스
• 영국
• 스페인
• 베네룩스
• 러시아
• 기타 유럽
• 중국
• 일본
• 한국
• 인도
• 말레이시아
• 인도네시아
• 싱가포르
• 호주 및 뉴질랜드
• GCC 국가
• 터키
• 남아프리카
• 기타 중동 및 아프리카

제19장 시장 구조 분석

• 기업 Tier별 시장 분석
• 주요 기업의 시장 점유율 분석
• 시장현재분석

제20장 경쟁 분석

• 경쟁 대시보드
• 경쟁 벤치마킹
• 경쟁의 상세
  • Allscripts Healthcare Solutions
  • Mckesson Corporation
  • Cerner Corporation
  • Phytel Inc
  • Medecision Inc
  • Athenahealth Inc
  • Novartis
  • Roche Holding AG
  • Bayer
  • GlaxoSmithkline
  • IQVIA

제21장 사용된 전제조건과 약어

제22장 조사 방법

JHS

영문 목차

영문목차

Persistence Market Research has recently published an extensive report on the global Patient Engagement Solution Market. This report provides an in-depth analysis of essential market dynamics, including drivers, trends, opportunities, and challenges, offering valuable insights into the market landscape.

Key Insights:

• Patient Engagement Solution Market Size (2024E): USD 21.3 Bn
• Projected Market Value (2033F): USD 50.7 Bn
• Global Market Growth Rate (CAGR 2024 to 2033): 13.2%

Patient Engagement Solution Market - Report Scope:

Patient engagement solutions represent a significant advancement in healthcare, focusing on improving patient participation in their own care. These solutions encompass a range of tools and technologies designed to facilitate communication between patients and healthcare providers, enhance patient education, and improve overall healthcare outcomes. The market includes platforms such as patient portals, mobile health apps, and remote monitoring systems. The growth of the patient engagement market is driven by the increasing emphasis on patient-centered care, advancements in digital health technologies, and the need for improved healthcare outcomes.

Market Growth Drivers:

The global patient engagement solution market is driven by several key factors, including the rising demand for personalized and patient-centered healthcare services. Technological advancements in digital health, such as telemedicine, mobile health applications, and wearable devices, are enhancing patient engagement and driving market expansion. Increased focus on chronic disease management and preventive care is also contributing to market growth, as these solutions enable better monitoring and management of health conditions. Additionally, supportive government initiatives and healthcare reforms aimed at improving patient care and outcomes are further propelling the adoption of patient engagement solutions.

Market Restraints:

Despite its growth potential, the patient engagement solution market faces challenges related to data security, privacy concerns, and technological integration. Ensuring the security and privacy of patient data is crucial for maintaining trust and compliance with regulations such as HIPAA. The integration of patient engagement solutions with existing healthcare systems can be complex and costly, posing a challenge for healthcare providers. Additionally, disparities in digital health literacy and access to technology among different patient populations may hinder the widespread adoption of these solutions.

Market Opportunities:

The patient engagement solution market offers substantial growth opportunities driven by technological innovations and evolving healthcare models. The integration of artificial intelligence (AI) and machine learning into patient engagement platforms can enhance personalized care and predictive analytics. Opportunities also exist in expanding these solutions to underserved and rural areas, where access to healthcare services may be limited. Strategic partnerships between technology providers, healthcare organizations, and payers can create new business models and drive market growth. Additionally, the growing focus on value-based care and patient satisfaction presents opportunities for developing innovative patient engagement solutions.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the patient engagement solution market globally?
• Which types of patient engagement solutions are gaining traction in different regions?
• How are technological advancements reshaping the competitive landscape of the patient engagement market?
• Who are the key players contributing to the patient engagement solution market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global patient engagement solution market?

Competitive Intelligence and Business Strategy:

Key players in the global patient engagement solution market, including companies such as Cerner Corporation, Allscripts Healthcare Solutions, and Medisafe, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced patient engagement tools, enhance interoperability with existing healthcare systems, and improve user experience. Collaborations with healthcare providers, technology firms, and regulatory bodies are essential to drive market adoption and address emerging needs. Additionally, a focus on data security, integration capabilities, and customer support helps to foster market growth and ensure the successful implementation of patient engagement solutions.

Key Companies Profiled:

• Allscripts Healthcare Solutions
• Mckesson Corporation
• Cerner Corporation
• Phytel Inc
• Medecision Inc
• Athenahealth Inc
• Novartis
• Roche Holding AG
• Bayer
• GlaxoSmithkline
• IQVIA

Key Segments of Patient Engagement Solution Market Industry Research

By Solution:

• Software
• Services

By Deployment:

• Cloud
• On Premise

By Application:

• Health Management
• Social Management
• Home Healthcare Management
• Financial Health Management

By End User:

• Patients
• Payers
• Healthcare Providers

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia Pacific
• Middle East and Africa

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Product Innovation / Development Trends

4. Pricing Analysis

• 4.1. Pricing Analysis, By Solution
  • 4.1.1. Subscription Pricing Model
  • 4.1.2. Perpetual Licensing
• 4.2. Average Pricing Analysis Benchmark

5. Global Patient Engagement Solution Market Demand (in Value in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

• 5.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
• 5.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
  • 5.2.1. Y-o-Y Growth Trend Analysis
  • 5.2.2. Absolute $ Opportunity Analysis

6. Market Background

• 6.1. Macro-Economic Factors
• 6.2. Forecast Factors - Relevance & Impact
• 6.3. Value Chain
• 6.4. COVID-19 Crisis - Impact Assessment
  • 6.4.1. Current Statistics
  • 6.4.2. Short-Mid-Long Term Outlook
  • 6.4.3. Likely Rebound
• 6.5. Market Dynamics
  • 6.5.1. Drivers
  • 6.5.2. Restraints
  • 6.5.3. Opportunities

7. Global Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033, by Solution

• 7.1. Introduction / Key Findings
• 7.2. Historical Market Size (US$ Bn) Analysis By Solution, 2019-2023
• 7.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Solution, 2024-2033
  • 7.3.1. Software
    • 7.3.1.1. Integrated Patient Engagement Software
    • 7.3.1.2. Standalone Software
      • 7.3.1.2.1. Scheduling Software
      • 7.3.1.2.2. Billing Software
      • 7.3.1.2.3. Secure Messaging Software
      • 7.3.1.2.4. Others
  • 7.3.2. Services
    • 7.3.2.1. Implementation and Integration
    • 7.3.2.2. Consulting
    • 7.3.2.3. Support and Maintenance
• 7.4. Market Attractiveness Analysis By Solution

8. Global Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033, by Deployment

• 8.1. Introduction / Key Findings
• 8.2. Historical Market Size (US$ Bn) Analysis By Deployment, 2019-2023
• 8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Deployment, 2024-2033
  • 8.3.1. Cloud
  • 8.3.2. On-Premise
• 8.4. Market Attractiveness Analysis By Deployment

9. Global Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033, By Application

• 9.1. Introduction / Key Findings
• 9.2. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
• 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Application, 2024-2033
  • 9.3.1. Health Management
  • 9.3.2. Social Management
  • 9.3.3. Home Healthcare Management
  • 9.3.4. Financial Health Management
  • 9.3.5. Others
• 9.4. Market Attractiveness Analysis By Application

10. Global Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033, By End User

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Bn) Analysis By End User, 2019-2023
• 10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
  • 10.3.1. Patients
  • 10.3.2. Payers
  • 10.3.3. Healthcare Providers
  • 10.3.4. Others
• 10.4. Market Attractiveness Analysis By End User

11. Global Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033, by Region

• 11.1. Introduction / Key Findings
• 11.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
• 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Region, 2024-2033
  • 11.3.1. North America
  • 11.3.2. Latin America
  • 11.3.3. Europe
  • 11.3.4. East Asia
  • 11.3.5. South Asia Pacific
  • 11.3.6. Middle East and Africa
• 11.4. Market Attractiveness Analysis By Region

12. North America Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033

• 12.1. Introduction
• 12.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 12.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2024-2033
  • 12.3.1. By Solution
  • 12.3.2. By Deployment
  • 12.3.3. By Application
  • 12.3.4. By End User
  • 12.3.5. By Country
    • 12.3.5.1. U.S.
    • 12.3.5.2. Canada
• 12.4. Market Attractiveness Analysis
  • 12.4.1. By Solution
  • 12.4.2. By Deployment
  • 12.4.3. By Application
  • 12.4.4. By End User
  • 12.4.5. By Country
• 12.5. Market Trends
• 12.6. Key Market Participants - Intensity Mapping

13. Latin America Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 13.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2024-2033
  • 13.3.1. By Solution
  • 13.3.2. By Deployment
  • 13.3.3. By Application
  • 13.3.4. By End User
  • 13.3.5. By Country
    • 13.3.5.1. Brazil
    • 13.3.5.2. Mexico
    • 13.3.5.3. Rest of Latin America
• 13.4. Market Attractiveness Analysis
  • 13.4.1. By Solution
  • 13.4.2. By Deployment
  • 13.4.3. By Application
  • 13.4.4. By End User
  • 13.4.5. By Country

14. Europe Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 14.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2024-2033
  • 14.3.1. By Solution
  • 14.3.2. By Deployment
  • 14.3.3. By Application
  • 14.3.4. By End User
  • 14.3.5. By Country
    • 14.3.5.1. Germany
    • 14.3.5.2. Italy
    • 14.3.5.3. France
    • 14.3.5.4. U.K.
    • 14.3.5.5. Spain
    • 14.3.5.6. BENELUX
    • 14.3.5.7. Russia
    • 14.3.5.8. Rest of Europe
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Solution
  • 14.4.2. By Deployment
  • 14.4.3. By Application
  • 14.4.4. By End User
  • 14.4.5. By Country

15. South Asia & Pacific Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 15.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2024-2033
  • 15.3.1. By Solution
  • 15.3.2. By Deployment
  • 15.3.3. By Application
  • 15.3.4. By End User
  • 15.3.5. By Country
    • 15.3.5.1. India
    • 15.3.5.2. Indonesia
    • 15.3.5.3. Malaysia
    • 15.3.5.4. Singapore
    • 15.3.5.5. Australia & New Zealand
    • 15.3.5.6. Rest of South Asia and Pacific
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Solution
  • 15.4.2. By Deployment
  • 15.4.3. By Application
  • 15.4.4. By End User
  • 15.4.5. By Country

16. East Asia Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 16.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2024-2033
  • 16.3.1. By Solution
  • 16.3.2. By Deployment
  • 16.3.3. By Application
  • 16.3.4. By End User
  • 16.3.5. By Country
    • 16.3.5.1. China
    • 16.3.5.2. Japan
    • 16.3.5.3. South Korea
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Solution
  • 16.4.2. By Deployment
  • 16.4.3. By Application
  • 16.4.4. By End User
  • 16.4.5. By Country

17. Middle East and Africa Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 17.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2024-2033
  • 17.3.1. By Solution
  • 17.3.2. By Deployment
  • 17.3.3. By Application
  • 17.3.4. By End User
  • 17.3.5. By Country
    • 17.3.5.1. GCC Countries
    • 17.3.5.2. Turkey
    • 17.3.5.3. South Africa
    • 17.3.5.4. Rest of Middle East and Africa
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Solution
  • 17.4.2. By Deployment
  • 17.4.3. By Application
  • 17.4.4. By End User
  • 17.4.5. By Country

18. Key Countries Analysis- Patient Engagement Solution Market

• 18.1. U.S. Patient Engagement Solution Market Analysis
  • 18.1.1. By Solution
  • 18.1.2. By Deployment
  • 18.1.3. By Application
  • 18.1.4. By End User
• 18.2. Canada Patient Engagement Solution Market Analysis
  • 18.2.1. By Solution
  • 18.2.2. By Deployment
  • 18.2.3. By Application
  • 18.2.4. By End User
• 18.3. Mexico Patient Engagement Solution Market Analysis
  • 18.3.1. By Solution
  • 18.3.2. By Deployment
  • 18.3.3. By Application
  • 18.3.4. By End User
• 18.4. Brazil Patient Engagement Solution Market Analysis
  • 18.4.1. By Solution
  • 18.4.2. By Deployment
  • 18.4.3. By Application
  • 18.4.4. By End User
• 18.5. Germany Patient Engagement Solution Market Analysis
  • 18.5.1. By Solution
  • 18.5.2. By Deployment
  • 18.5.3. By Application
  • 18.5.4. By End User
• 18.6. Italy Patient Engagement Solution Market Analysis
  • 18.6.1. By Solution
  • 18.6.2. By Deployment
  • 18.6.3. By Application
  • 18.6.4. By End User
• 18.7. France Patient Engagement Solution Market Analysis
  • 18.7.1. By Solution
  • 18.7.2. By Deployment
  • 18.7.3. By Application
  • 18.7.4. By End User
• 18.8. U.K. Patient Engagement Solution Market Analysis
  • 18.8.1. By Solution
  • 18.8.2. By Deployment
  • 18.8.3. By Application
  • 18.8.4. By End User
• 18.9. Spain Patient Engagement Solution Market Analysis
  • 18.9.1. By Solution
  • 18.9.2. By Deployment
  • 18.9.3. By Application
  • 18.9.4. By End User
• 18.10. BENELUX Patient Engagement Solution Market Analysis
  • 18.10.1. By Solution
  • 18.10.2. By Deployment
  • 18.10.3. By Application
  • 18.10.4. By End User
• 18.11. Russia Patient Engagement Solution Market Analysis
  • 18.11.1. By Solution
  • 18.11.2. By Deployment
  • 18.11.3. By Application
  • 18.11.4. By End User
• 18.12. Rest of Europe Patient Engagement Solution Market Analysis
  • 18.12.1. By Solution
  • 18.12.2. By Deployment
  • 18.12.3. By Application
  • 18.12.4. By End User
• 18.13. China Patient Engagement Solution Market Analysis
  • 18.13.1. By Solution
  • 18.13.2. By Deployment
  • 18.13.3. By Application
  • 18.13.4. By End User
• 18.14. Japan Patient Engagement Solution Market Analysis
  • 18.14.1. By Solution
  • 18.14.2. By Deployment
  • 18.14.3. By Application
  • 18.14.4. By End User
• 18.15. South Korea Patient Engagement Solution Market Analysis
  • 18.15.1. By Solution
  • 18.15.2. By Deployment
  • 18.15.3. By Application
  • 18.15.4. By End User
• 18.16. India Patient Engagement Solution Market Analysis
  • 18.16.1. By Solution
  • 18.16.2. By Deployment
  • 18.16.3. By Application
  • 18.16.4. By End User
• 18.17. Malaysia Patient Engagement Solution Market Analysis
  • 18.17.1. By Solution
  • 18.17.2. By Deployment
  • 18.17.3. By Application
  • 18.17.4. By End User
• 18.18. Indonesia Patient Engagement Solution Market Analysis
  • 18.18.1. By Solution
  • 18.18.2. By Deployment
  • 18.18.3. By Application
  • 18.18.4. By End User
• 18.19. Singapore Patient Engagement Solution Market Analysis
  • 18.19.1. By Solution
  • 18.19.2. By Deployment
  • 18.19.3. By Application
  • 18.19.4. By End User
• 18.20. Australia and New Zealand Patient Engagement Solution Market Analysis
  • 18.20.1. By Solution
  • 18.20.2. By Deployment
  • 18.20.3. By Application
  • 18.20.4. By End User
• 18.21. GCC Countries Patient Engagement Solution Market Analysis
  • 18.21.1. By Solution
  • 18.21.2. By Deployment
  • 18.21.3. By Application
  • 18.21.4. By End User
• 18.22. Turkey Patient Engagement Solution Market Analysis
  • 18.22.1. By Solution
  • 18.22.2. By Deployment
  • 18.22.3. By Application
  • 18.22.4. By End User
• 18.23. South Africa Patient Engagement Solution Market Analysis
  • 18.23.1. By Solution
  • 18.23.2. By Deployment
  • 18.23.3. By Application
  • 18.23.4. By End User
• 18.24. Rest of Middle East and Africa Patient Engagement Solution Market Analysis
  • 18.24.1. By Solution
  • 18.24.2. By Deployment
  • 18.24.3. By Application
  • 18.24.4. By End User

19. Market Structure Analysis

• 19.1. Market Analysis by Tier of Companies
• 19.2. Market Share Analysis of Top Players
• 19.3. Market Presence Analysis

20. Competition Analysis

• 20.1. Competition Dashboard
• 20.2. Competition Benchmarking
• 20.3. Competition Deep Dive
  • 20.3.1. Allscripts Healthcare Solutions
    • 20.3.1.1. Business Overview
    • 20.3.1.2. Product Portfolio
    • 20.3.1.3. Profitability by Market Segments (Business Segments/Region)
    • 20.3.1.4. Key Strategy & Developments
  • 20.3.2. Mckesson Corporation
    • 20.3.2.1. Business Overview
    • 20.3.2.2. Product Portfolio
    • 20.3.2.3. Profitability by Market Segments (Business Segments/Region)
    • 20.3.2.4. Key Strategy & Developments
  • 20.3.3. Cerner Corporation
    • 20.3.3.1. Business Overview
    • 20.3.3.2. Product Portfolio
    • 20.3.3.3. Profitability by Market Segments (Business Segments/Region)
    • 20.3.3.4. Key Strategy & Developments
  • 20.3.4. Phytel Inc
    • 20.3.4.1. Business Overview
    • 20.3.4.2. Product Portfolio
    • 20.3.4.3. Profitability by Market Segments (Business Segments/Region)
    • 20.3.4.4. Key Strategy & Developments
  • 20.3.5. Medecision Inc
    • 20.3.5.1. Business Overview
    • 20.3.5.2. Product Portfolio
    • 20.3.5.3. Profitability by Market Segments (Business Segments/Region)
    • 20.3.5.4. Key Strategy & Developments
  • 20.3.6. Athenahealth Inc
    • 20.3.6.1. Business Overview
    • 20.3.6.2. Product Portfolio
    • 20.3.6.3. Profitability by Market Segments (Business Segments/Region)
    • 20.3.6.4. Key Strategy & Developments
  • 20.3.7. Novartis
    • 20.3.7.1. Business Overview
    • 20.3.7.2. Product Portfolio
    • 20.3.7.3. Profitability by Market Segments (Business Segments/Region)
    • 20.3.7.4. Key Strategy & Developments
  • 20.3.8. Roche Holding AG
    • 20.3.8.1. Business Overview
    • 20.3.8.2. Product Portfolio
    • 20.3.8.3. Profitability by Market Segments (Business Segments/Region)
    • 20.3.8.4. Key Strategy & Developments
  • 20.3.9. Bayer
    • 20.3.9.1. Business Overview
    • 20.3.9.2. Product Portfolio
    • 20.3.9.3. Profitability by Market Segments (Business Segments/Region)
    • 20.3.9.4. Key Strategy & Developments
  • 20.3.10. GlaxoSmithkline
    • 20.3.10.1. Business Overview
    • 20.3.10.2. Product Portfolio
    • 20.3.10.3. Profitability by Market Segments (Business Segments/Region)
    • 20.3.10.4. Key Strategy & Developments
  • 20.3.11. IQVIA
    • 20.3.11.1. Business Overview
    • 20.3.11.2. Product Portfolio
    • 20.3.11.3. Profitability by Market Segments (Business Segments/Region)
    • 20.3.11.4. Key Strategy & Developments

21. Assumptions and Acronyms Used

22. Research Methodology

관련자료